According to Future Market Insights research, during the projected period, the global veterinary point of care market is expected to grow at a CAGR of 8.2%. The market value is projected to increase from USD 1.7 Billion in 2023 to USD 3.8 Billion by 2033.
The veterinary point of care market was valued at USD 1.6 Billion at the end of 2022 and is anticipated to exhibit Y-o-Y growth of 7.4% in 2023.
Market Outlook:
| Attribute | Details |
|---|---|
| Veterinary Point of Care Market Size (2023) | USD 1.7 Billion |
| Veterinary Point of Care Projected Market Value (2033) | USD 3.8 Billion |
| Global Veterinary Point of Care Market Growth Rate (2023 to 2033) | 8.2% CAGR |
| Market Share of Top 5 Countries | 57.3% |
| Key Players | Zoetis IDEXX Laboratories Inc.; Virbac; Heska Corporation; Thermo Fisher Scientific Inc.; SOUND; Mindray; Esaote SPA; FUJIFILM Corporation; Woodley Equipment Company Ltd. |
As assessed by Future Market Insights, in the product segment, in 2022 instruments and devices held a dominating stance within the global market with around 56.3% value share.
The growing adoption of pets around the globe together with rising awareness regarding veterinary healthcare, has significantly driven the market growth for veterinary point of care globally. Point of care diagnostics in veterinary allows for rapid detection of pathogens in a non-laboratory settings.
With the advent of cutting-edge technologies like Real-time PCR, and Next Generation Sequencing (NGS), lab diagnosis of animal disease has tremendously advanced over past few decades. Currently, there are wide variety of assays based on antigens, antibodies, and nucleic acid, available in the market.
Many research institutions are undertaking activities to develop new test or improvising the existing tests in terms of specificity, affordability, sensitivity and turnaround time. POCT has been increasingly becoming popular in improving wellbeing of animal health especially in the resource-limited settings.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market value for veterinary point of care was around 4.4% of the overall USD 36.6 Billion global point of care diagnostics market in 2022. The global market recorded a historic CAGR of 6.3% in the last 10 years from 2012 to 2022.
Telemedicine, which involves remote diagnosis and treatment of animals using telecommunications technology, has gained significant traction in the veterinary industry. It allows veterinarians to provide consultative services and address non-emergency cases, and offer follow-up care without the need for in-person visits.
Telemedicine platforms and mobile applications are being developed specifically for veterinary use, supporting virtual consultations, remote patient monitoring and prescription fulfilment.
Telemedicine not only facilitates remote consultations but also opens opportunities for additional services, veterinarians can offer tele-triage services, where they can assess the severity of a pet’s condition and advice the pet owners on whether the emergency care is necessary or not which propels the veterinary point of care market.
Regulatory agencies such as Food and Drug Administration in the USA, require comprehensive studies and evidence to demonstrate the efficacy and safety of veterinary drugs.
This assurance of safety and effectiveness gives veterinarians and pet owners confidence in using these drugs. Regulatory authorities are increasingly focusing on streamlining the drug approval process, especially for innovative and critical drugs.
Regulatory frameworks recognize the unique aspects of veterinary medicine, which differs from human medicine. They take into account the factors such as target animal species, dosage forms, administration routes, and specific disease considerations in the animals.
This tailored approach ensures that veterinary drugs meets the specific requirement of animal health, facilitating the development of specialised drug formulations that are suitable for point of care use, which fuels the demand for the veterinary point of care.
Principal Consultant
Training ensures that veterinary personnel are familiarized with the device's user interface, control buttons, sample-collecting techniques, and the methodical test-running procedure, thereby enabling mistakes to be prevented, the accuracy of outcomes to be increased and patient safety to be guaranteed.
In addition, proper sample management and collection are considered essential for obtaining accurate results, and veterinary practitioners must be taught the correct methods for collecting, storing, and transporting samples, as well as being able to recognize potential causes of error or contamination and comprehend the specific specifications of various point of care (POC) tests.
Moreover, the correct interpretation of POC test results when making treatment selections is of critical importance, and the main emphasis of training should be on understanding the significance of various test parameters, reference intervals, and potential differences in results.
Veterinarians should be trained to differentiate between normal and abnormal test results and to understand the therapeutic implications of those findings.
The USA market contributes a market share of 91.1% to the North American market in 2022 and is expected to register to grow at a high pace during the forecast period.
With the growing importance of pets in people’s lives, there has been a significant increase in spending on veterinary healthcare. The advances in veterinary medicine have led to more sophisticated and expensive treatments for pets.
Veterinary medicine has seen advancements in diagnostics technology, surgical techniques, and medical treatments. These advancements have expanded the range of treatments available for pets offering more options for addressing various health conditions.
However, these advanced treatments often come at a higher cost, contributing to the overall increase in veterinary healthcare expenditure, which propels the veterinary point of care market.
The Germany market hold around 23.1% market share within the Europe market in 2022.
Urbanization has led to smaller living spaces, making it more practical for people to have pets that can comfortably live indoors such as cats and small dogs. Additionally, changing demographics, such as an increase in single-person households and an ageing population, have contributed to the desire for companionship and emotional support that pets can provide.
Moreover, there is a growing recognition of the positive impact pets have on mental and physical health. As a result of these factors, the pet population is steadily rising in Germany, which increases pet ownership which has a direct impact on the demand for veterinary point of care.
Pet owners are willing to invest more in the medical well-being of their animals leading to a rise in demand for veterinary point of care.
China held about 48.1% of the total East Asia market share in 2022.
In the veterinary point-of-care market, there is now a greater recognition of the role that animals play in transmitting zoonotic diseases. Veterinarians and pet owners are becoming more proactive in identifying and addressing this disease to protect both animal and human health.
Overall, the growing focus on zoonotic disease in the veterinary point of care market stems from the recognition of the public health risk posed by this disease. With the aim of early detection, and rapid intervention the market is experiencing an increased demand for veterinary point of care testing solutions.
China has a rapidly evolving veterinary market, with both domestic and international players actively participating. The increasing competition drives innovation and encourages the development of new POC diagnostic solutions tailored to the specific needs of the Chinese market
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The instruments and devices segment held around 56.3% share within the product segment of the global market in 2022.
Instruments and devices play a vital role in the diagnosis and treatment of veterinary patients at the point of care, offering immediate results and facilitating prompt decision-making.
Advancements in technology have led to the development of sophisticated and portable diagnostic instruments and devices, allowing veterinarians to perform a wide range of tests on-site, including blood analysis, imaging, and monitoring vital signs.
Moreover, the instruments and devices segment has witnessed significant investment and innovation from manufacturers, resulting in a wide range of products tailored specifically for the veterinary point-of-care market.
Which collectively contribute to the leading position of the instruments and devices segment in the veterinary point-of-care market's product segment.
In 2022, the companion animals segment accounted for about 64.7% of the global market share by animal type.
Companion animals have a significant presence in households worldwide, with high rates of pet ownership. This translates into a larger target market for veterinary point-of-care solutions. Companion animals often receive regular preventive care, necessitating the use of point-of-care diagnostics for routine check-ups and screenings.
Pet owners' increasing awareness of their pets' health and well-being drives the demand for convenient and accessible veterinary care, where point-of-care solutions play a crucial role.
Moreover, advancements in point-of-care technologies have made it easier to develop and market solutions specifically tailored to the needs of companion animal healthcare.
The blood segment held a market share of 34.7% within the sample segment in 2022.
As blood provides information about an animal's health status, allowing for comprehensive diagnostic evaluation. It contains various biomarkers that can indicate organ function, infection, inflammation, and other health parameters.
And advancements in point-of-care technologies have made it easier to perform on-site blood testing with quick turnaround times due to which veterinary professionals can obtain rapid results for complete blood counts, blood chemistry profiles, coagulation tests, and other diagnostic parameters using handheld devices or POC analysers.
Clinical pathology held a share of about 36.9% in 2022, within the application segment of the global market.
Clinical pathology segments are leading in the application segment of the veterinary point-of-care market due to their ability to provide rapid and on-site diagnostic information, enabling timely treatment decisions.
These segments encompass tests such as complete blood counts (CBC), blood chemistry panels, urinalysis, and faecal examinations, which are crucial for evaluating overall health, detecting infections, assessing organ function, and monitoring treatment responses in veterinary patients.
The convenience, efficiency and immediate results offered by clinical pathology POC tests contribute to their prominence in the veterinary point-of-care market.
The veterinary point of care market is characterized by a significant level of competition. Major market players are actively seeking to expand their market presence in emerging economies through strategic partnerships and mergers and acquisitions.
Additionally, they are prioritizing the development and launch of innovative, cutting-edge point of care diagnostics for animal health. Our analysis of the competitive environment reveals that several global and local businesses currently dominate the market shares. Along with collaborating with important market players through mergers, acquisitions, and alliances.
Some key instances of development include:
Similarly, the team at Future Market Insights has tracked recent developments related to companies in the veterinary point of care market, which are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2012 to 2022 |
| Market Analysis | USD Million for Value, Units for Volume |
| Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East and Africa. |
| Key Countries Covered | USA, Canada, Brazil, Argentina, Mexico, Germany, France, UK, Italy, Spain, Russia, BENELUX, India, Thailand, Malaysia, Indonesia, China, Japan, South Korea, Australia, New Zealand, Türkiye, GCC Countries, Northern Africa, and South Africa |
| Key Market Segments Covered | Product, Animal Type, Sample, Application, End User and Region |
| Key Companies Covered | Zoetis; IDEXX Laboratories, Inc.; Virbac; Heska Corporation; Thermo Fisher Scientific Inc.; SOUND; Mindray; Esaote SPA; FUJIFILM Corporation; Woodley Equipment Company Ltd |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The global market is forecasted to follow a y-o-y growth rate of roughly 7.4% through 2033.
The veterinary point of care market size projected to close on a valuation of USD 3.8 billion by 2033.
Increasing companion animal population has boosted the veterinary point of care demand.
The companion animals segment contributed for almost 64.7% of the global sales.
The United States leads in demand for such services and held 91.1% of North America market in 2022.
1. Executive Summary 2. Market Overview 3. Key Market Trends 4. Value Added Insights 5. Market Background 6. Global Market Demand (in Volume) Analysis 2012 to 2022 and Forecast, 2023 to 2033 7. Global Market - Pricing Analysis 8. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product 8.1. Consumables, Reagents & Kits 8.2. Instruments & Devices 9. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Animal Type 9.1. Companion Animals 9.2. Livestock Animals 10. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Sample 10.1. Blood 10.2. Urine 10.3. Fecal 10.4. Imaging 10.5. Others 11. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Application 11.1. Clinical Pathology 11.2. Bacteriology 11.3. Virology 11.4. Parasitology 11.5. Others 12. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By End User 12.1. Veterinary Hospitals 12.2. Specialty Veterinary Centers 12.3. Veterinary Mobile Facilities 12.4. Veterinary Clinics 13. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Region 13.1. North America 13.2. Latin America 13.3. Europe 13.4. East Asia 13.5. South Asia 13.6. Oceania 13.7. Middle East and Africa (MEA) 14. North America Analysis 2012 to 2022 and Forecast 2023 to 2033 15. Latin America Market Analysis 2012 to 2022 and Forecast 2023 to 2033 16. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033 17. East Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033 18. South Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033 19. Oceania Market Analysis 2012 to 2022 and Forecast 2023 to 2033 20. Middle East and Africa (MEA) Market Analysis 2012 to 2022 and Forecast 2023 to 2033 21. Market Structure Analysis 22. Competition Analysis 22.1. Zoetis 22.2. IDEXX Laboratories, Inc. 22.3. Virbac 22.4. Heska Corporation 22.5. Thermo Fisher Scientific Inc. 22.6. SOUND 22.7. Mindray 22.8. Esaote SPA 22.9. FUJIFILM Corporation 22.10. Woodley Equipment Company Ltd 23. Assumptions and Acronyms Used 24. Research Methodology
Explore Healthcare Insights
View Reports
Veterinary Point of Care Market
